Tumor Necrosis Factor Alpha Induced Protein 3 (TNFaIP3)
[Edit]A20; OTUD7C; TNFA1P2; OTU domain-containing protein 7C; Putative DNA-binding protein A20; Zinc finger protein A20
Tumor necrosis factor, alpha-induced protein 3 is a zinc finger protein, and has been shown to inhibit NF-kappa B activation as well as TNF-mediated apoptosis. Knockout studies of a similar gene in mice suggested that this gene is critical for limiting inflammation by terminating TNF-induced NF-kappa B responses.
Essential component of a ubiquitin-editing protein complex, comprising also RNF11, ITCH and TAX1BP1, that ensures the transient nature of inflammatory signaling pathways. Upon TNF stimulation, deubiquitinates 'Lys-63'-polyubiquitin chains on RIPK1 and catalyzes the formation of 'Lys-48'-polyubiquitin chains. This leads to RIPK1 proteosomal degradation and consequently termination of the TNF- or LPS-mediated activation of NF-kappa-B.
Organism species: Homo sapiens (Human)
CATALOG NO. | PRODUCT NAME | APPLICATIONS | |
Proteins | RPC796Hu01 | Recombinant Tumor Necrosis Factor Alpha Induced Protein 3 (TNFaIP3) | Positive Control; Immunogen; SDS-PAGE; WB. |
Antibodies | PAC796Hu01 | Polyclonal Antibody to Tumor Necrosis Factor Alpha Induced Protein 3 (TNFaIP3) | WB; IHC; ICC; IP. |
MAC796Hu21 | Monoclonal Antibody to Tumor Necrosis Factor Alpha Induced Protein 3 (TNFaIP3) | WB; IHC; ICC; IP. | |
Assay Kits | SEC796Hu | ELISA Kit for Tumor Necrosis Factor Alpha Induced Protein 3 (TNFaIP3) | Enzyme-linked immunosorbent assay for Antigen Detection. |
SCC796Hu | CLIA Kit for Tumor Necrosis Factor Alpha Induced Protein 3 (TNFaIP3) | Chemiluminescent immunoassay for Antigen Detection. |
Organism species: Mus musculus (Mouse)
CATALOG NO. | PRODUCT NAME | APPLICATIONS | |
Proteins | n/a | Recombinant Tumor Necrosis Factor Alpha Induced Protein 3 (TNFaIP3) | Recombinant Protein Customized Service Offer |
Antibodies | n/a | Monoclonal Antibody to Tumor Necrosis Factor Alpha Induced Protein 3 (TNFaIP3) | Monoclonal Antibody Customized Service Offer |
n/a | Polyclonal Antibody to Tumor Necrosis Factor Alpha Induced Protein 3 (TNFaIP3) | Polyclonal Antibody Customized Service Offer | |
Assay Kits | n/a | CLIA Kit for Tumor Necrosis Factor Alpha Induced Protein 3 (TNFaIP3) | CLIA Kit Customized Service Offer |
n/a | ELISA Kit for Tumor Necrosis Factor Alpha Induced Protein 3 (TNFaIP3) | ELISA Kit Customized Service Offer |
- "The A20 cDNA induced by tumor necrosis factor alpha encodes a novel type of zinc finger protein."J. Biol. Chem. 265:14705-14708(1990) [PubMed] [Europe PMC] [Abstract]
- "Complete sequencing and characterization of 21,243 full-length human cDNAs." Nat. Genet. 36:40-45(2004) [PubMed] [Europe PMC] [Abstract]
- "The DNA sequence and analysis of human chromosome 6." Nature 425:805-811(2003) [PubMed] [Europe PMC] [Abstract]
- "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)."Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract]
- "The full-ORF clone resource of the German cDNA consortium."BMC Genomics 8:399-399(2007) [PubMed] [Europe PMC] [Abstract]
- "The tumor necrosis factor-inducible zinc finger protein A20 interacts with TRAF1/TRAF2 and inhibits NF-kappaB activation."Proc. Natl. Acad. Sci. U.S.A. 93:6721-6725(1996) [PubMed] [Europe PMC] [Abstract]
- "A20 inhibits NF-kappaB activation independently of binding to 14-3-3 proteins."Biochem. Biophys. Res. Commun. 238:590-594(1997) [PubMed] [Europe PMC] [Abstract]
- "Epstein-Barr virus-encoded latent membrane protein 1 activates the JNK pathway through its extreme C-terminus via a mechanism involving TRADD and TRAF2."J. Virol. 73:1023-1035(1999) [PubMed] [Europe PMC] [Abstract]
- "The zinc finger protein A20 interacts with a novel anti-apoptotic protein which is cleaved by specific caspases."Oncogene 18:4182-4190(1999) [PubMed] [Europe PMC] [Abstract]
- "Isolation and characterization of two novel A20-like proteins."Biochem. J. 357:617-623(2001) [PubMed] [Europe PMC] [Abstract]
- "Zinc-finger protein A20, a regulator of inflammation and cell survival, has de-ubiquitinating activity."Biochem. J. 378:727-734(2004) [PubMed] [Europe PMC] [Abstract]
- "De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signalling."Nature 430:694-699(2004) [PubMed] [Europe PMC] [Abstract]
- "Global, in vivo, and site-specific phosphorylation dynamics in signaling networks."Cell 127:635-648(2006) [PubMed] [Europe PMC] [Abstract]
- "ABIN-1 binds to NEMO/IKKgamma and co-operates with A20 in inhibiting NF-kappaB."J. Biol. Chem. 281:18482-18488(2006) [PubMed] [Europe PMC] [Abstract]
- "T cell antigen receptor stimulation induces MALT1 paracaspase-mediated cleavage of the NF-kappaB inhibitor A20."Nat. Immunol. 9:263-271(2008) [PubMed] [Europe PMC] [Abstract]
- "A quantitative atlas of mitotic phosphorylation."Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008) [PubMed] [Europe PMC] [Abstract]
- "The zinc finger protein A20 targets TRAF2 to the lysosomes for degradation."Biochim. Biophys. Acta 1793:346-353(2009) [PubMed] [Europe PMC] [Abstract]
- "The ubiquitin-editing enzyme A20 requires RNF11 to downregulate NF-kappaB signalling."EMBO J. 28:513-522(2009) [PubMed] [Europe PMC] [Abstract]
- "A20 negatively regulates T cell receptor signaling to NF-kappaB by cleaving Malt1 ubiquitin chains."J. Immunol. 182:7718-7728(2009) [PubMed] [Europe PMC] [Abstract]
- "Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions."Sci. Signal. 2:RA46-RA46(2009) [PubMed] [Europe PMC] [Abstract]
- "Cleavage by MALT1 induces cytosolic release of A20."Biochem. Biophys. Res. Commun. 400:543-547(2010) [PubMed] [Europe PMC] [Abstract]
- "Direct, noncatalytic mechanism of IKK inhibition by A20."Mol. Cell 44:559-571(2011) [PubMed] [Europe PMC] [Abstract]
- "N-terminal acetylome analyses and functional insights of the N-terminal acetyltransferase NatB."Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012) [PubMed] [Europe PMC] [Abstract]
- "OTU deubiquitinases reveal mechanisms of linkage specificity and enable ubiquitin chain restriction analysis."Cell 154:169-184(2013) [PubMed] [Europe PMC] [Abstract]
- "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome."J. Proteomics 96:253-262(2014) [PubMed] [Europe PMC] [Abstract]
- "Solution structure of the A20-type zinc finger domains from human tumor necrosis factor, alpha-induced protein 3."Submitted (OCT-2007) to the PDB data bank
- "Structure of the A20 OTU domain and mechanistic insights into deubiquitination."Biochem. J. 409:77-85(2008) [PubMed] [Europe PMC] [Abstract]
- "Molecular basis for the unique deubiquitinating activity of the NF-kappaB inhibitor A20."J. Mol. Biol. 376:526-540(2008) [PubMed] [Europe PMC] [Abstract]
- "Ubiquitin binding to A20 ZnF4 is required for modulation of NF-kappaB signaling."Mol. Cell 40:548-557(2010) [PubMed] [Europe PMC] [Abstract]